Devon Energy’s premium sale to Enbridge and MPLX highlights hidden midstream value in upstream portfolios and Texas gas ...

Biotech company Amgen (NASDAQ:AMGN) reported Q1 CY2025 results , with sales up 9.4% year on year to $8.15 billion. The company expects the full year’s revenue to be around $35 billion, close to ...

We believe that Merck KGaA enjoys a narrow moat, driven by intangible assets and switching costs which are prevalent in its Life Science and Electronics businesses. A few acquisitions to fill gaps in ...

Regeneron earns a buy rating with strong profit margins, low debt, and growth potential. Discover why shares may see a 39% ...